Research and Markets: Thrombotic Thrombocytopenic Purpura Pipeline Insights 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/zk2m3f/thrombotic) has announced the addition of the "Thrombotic Thrombocytopenic Purpura-Pipeline Insights" report to their offering.

Thrombotic Thrombocytopenic Purpura - Pipeline Insights provides in-depth analysis of the pipeline assets across Thrombotic Thrombocytopenic Purpura. The main objective of this report is to track competitor pipeline molecules, related research activities, technology, collaborations, and in-licensing and out-licensing deals. The Thrombotic Thrombocytopenic Purpura Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Thrombotic Thrombocytopenic Purpura - Pipeline Insights Report covers the Thrombotic Thrombocytopenic Purpura pipeline molecules at various stages of development, like pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Thrombotic Thrombocytopenic Purpura-related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in the pipeline for Thrombotic Thrombocytopenic Purpura.

Scope

- The report provides a Thrombotic Thrombocytopenic Purpura Landscape across the globe

- The report provides drug profiles which include product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Thrombotic Thrombocytopenic Purpura pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Thrombotic Thrombocytopenic Purpura and also provides company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/zk2m3f/thrombotic.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals